NPC Archive Item: NICE publishes clinical guideline on neuropathic pain

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2 June 2010 NICE has published a new clinical guideline on the pharmacological management of neuropathic pain in adults in non-specialist settings (CG96). This updates and replaces recommendations on the […]

NPC Archive Item: EMEA recommends withdrawal of co-proxamol

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2nd July 2009 The EMEA has recommended that the marketing authorisations for dextropropoxyphene-containing medicines are withdrawn across the European Union (EU) because their benefits do not outweigh their risks. […]

NPC Archive Item: Combination therapy with DMARDs is BeSt

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 5th February 2009 Four different DMARD treatment strategies in people with recent onset rheumatoid arthritis significantly improved patient-orientated outcomes after two years. Earlier improvements were seen in those initially […]

NPC Archive Item: NICE publishes clinical guidance on management of rheumatoid arthritis

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 27th February 2009 The NICE guideline (CG79) covers the management of rheumatoid arthritis (RA) of recent onset and more established disease. It includes sections on diagnosis and referral, pharmacological […]

NPC Archive Item: All non-analgesic drug classes are similarly effective in the treatment of neuropathic pain

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 26th January 2009 A Canadian Health Technology Assessment concludes that, in patients with neuropathic pain, there is no statistically significant difference in clinical response rates between tricyclic antidepressants, anticonvulsants […]